Therapeutic applications of implantable drug delivery systems

Journal of Pharmacological and Toxicological Methods

Volumn 40, Issue 1, 1998, Pages 1-12

  Dash, Alekha K ^a   Cudworth II, Greggrey C ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

Biodegradable; Dosage forms; Drug delivery systems; Implantable pumps; Implants; Nonbiodegradable

Indexed keywords

DRUG; POLYMER;

BIODEGRADATION; COST EFFECTIVENESS ANALYSIS; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; HYDROGEL; IMPLANTABLE PORT SYSTEM; IMPLANTATION; MINIPUMP; PUMP; RESERVOIR; REVIEW;

ANIMALS; BIODEGRADATION, ENVIRONMENTAL; EXCIPIENTS; HUMANS; INFUSION PUMPS, IMPLANTABLE;

EID: 0032408601     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8719(98)00027-6     Document Type: Review

References (57)

1. Bajpai PK (1983) Biodegradable scaffolds in orthopedic, oral, and maxillofacial surgery: In Biomaterials in Reconstructive Surgery. Ed., LR Rubin, St. Louis: Mosby, pp. 312-328.
2. Bajpai PK (1989) Ceramic implantable drug delivery system. Trend Biomat Art Org 3:50-60.
3. Baker R (1987) Controlled Release of Biologically Active Agents. New York: John Wiley, pp. 40, 56.
4. Barrera D, Zylstra E, Lansbury PT, Langer R,(1993) Synthesis and RGD peptide modification of a new biodegradable copolymer: poly(lactic acid-co-lysine). J Am Chem Soc 115:11010-11011.
5. Blackshear PJ, Rhode TH (1983) Artificial devices for insulin infusion in the treatment of patients with diabetes mellitus. In Controlled Drug Delivery, Vol. 2. Clinical Applications. Ed., SD Burk. Boca Raton, FL, CRC Press, p. 11.
6. Brown LR, Edelman ER, Fischel-Ghodsian F, Langer R (1996) Characterization of glucose mediated insulin release form implantable polymers. J Pharm Sci 85:1341-1344.
7. Brown LR, Wei CL, Langer R (1983) In vivo and in vitro release of macromolecules form polymeric drug delivery systems. J Pharm Sci 72:1181-1185.
8. Buchholz HW, Engelbrecht H (1970) Depot effect of various antibiotics mixed with Palacos resins. Chirurg 40:511-515.
9. Buchwald H, Rhode TD, Schneider PD, Varco RL, Blackshean PJ (1980a) Long-term intravenous heparin administration implantable infusion pump in ambulatory patients with recurrent venous thrombosis. Surgery 88:507-518.
10. Buchwald H, Grage TG, Vassilopoulos PP, Rhode TD, Varco RL, Blacksher PJ (1980b) Intraarterial infusion of chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer 45:866 -869.
11. Chien YW (1978) In Sustained and Controlled Release Drug Delivery Systems. Ed., JR Robinson. New York: Marcel Dekker, Methods to achieve sustained drug delivery - The physical approach: Implants. p. 211-349.
12. Conforti A, Bertani S, Lussignoli S, Grigolin L, Terzi M, Lora S, Calieeti P, Marsilio F, Veronese FM (1996) Anti-inflammatory activity of polyphosphazene based naproxen slow release system. J Pharm Pharmacol 48:468-473.
13. Dash AK, Suryanarayanan R (1992) An implantable dosage form for the treatment of bone infections. Pharm Res 9:993-1002.
14. Dagani R (1993) Biodegradable copolymer eyed as tissue matrix. Chem Eng News 22:5.
15. Danckwerts M, Fassihi A (1991) Implantable controlled release drug delivery systems: a Review. Drug Dev Ind Pharm 17:1465-1502.
16. During MJ, Freese A, Sabel BA, Saltzman WM, Deutch A, Roth RH, Langer R (1989) Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neuro 25:351-356.
17. Fara JW, Ray N (1988) Osmotic pumps. In Drug Delivery Devices: Fundamentals and Applications. Ed., P Tyle. New York: Marcel Dekker, pp. 1-41.
18. Farcinio H (1996) Product or package? novel drug delivery systems blur the line. Pharm Tech Jan:26-34.
19. Ferguson TH, Needham GF, Wagner JF (1988) Compudose: an implant system for growth promotion and feed efficiency in cattle. J Contr Rel 8:45-54.
20. Graham NB (1978) Polymeric inserts and implants for the controlled release of drugs. Br Poly J 10:260-266.
21. Greco F, Palma L, Specchia N, Jacobelli S Gaggini C (1992) Polymethylmethacrylate-antiblastic drug compounds: an in vitro study assessing the cytotoxic effect in cancer cell lines-a new method for local chemotherapy of bone metastasis. Orthopedics 15:189-194.
22. Gupta PK, Hung CT, Perrier DG (1987) Quantitation of the release of doxorubicin form colloidal dosage forms using dynamic dialysis. J Pharm Sci 76:141-145.
23. Gurny R, Simmons SP, Bnaker GS, Meeker R, Myers RD (1979) A new biocompatible drug delivery system for chronic implantation in animal brain. Pharm Acta Helv 54:349-352.
24. Higuchi T (1961) Rate of release of medicaments from ointment base containing drugs in suspension. J Pharm Sci 50:874-879.
25. Hill-West JL, Dunn RC, Hubbell JA (1995) Local release of fibrinolytic agents for adhesion prevention. J Surg Res 59:759-763.
26. Hopfenberg HB (1976) Controlled release form erodible slabe, cylinders and spheres: controlled release polymeric formulations. ACS Symposium Series. vol 33. pp. 26-32.
27. Juni K, Ogata J, Nakano M, Ichihara T, Mori K, Akagi M (1985) Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing doxorubicin. Chem Pharm Bull 33:313-318.
28. Kirkpatric DK, Tractenberg LS, Mangino PD(1985) In vitro characteristics of tobramycin-PMMA beads: compressive strength and leaching. Orthopedics 8:1130-1134.
29. Klemm K (1977) Die Behandlung chronischer Knocker-infektionen mit Gentamycin-PMMA-Ketten and Kugelen. In Gentamycin-PMMA-Kette. Gentamycin-PMMA-Kugelin Symposium. Ed., H. Conten. Munchen, Erlaner: VLE Verlag, pp. 20-25.
30. Langer R (1986) Implantable controlled release systems. In Methods of Drug Delivery. Ed., GM Ihler. New York: Pergamon Press, pp. 121-137.
31. Lesser GJ, Grossman SA, Leong KW, Lo H, Eller S (1996) In vitro and in vivo studies of subcutaneous hydromorphone implants designed for the treatment of cancer pain. Pain 65:265-272.
32. Lewis DH (1990) Controlled release of bioactive agents from lactide/ glycolide polymers. In Biodegradable Polymers as Drug Delivery Systems. Ed., M Chasin R Langer, New York: Marcel Dekker, pp. 1-41.
33. Mader K, Bacic G, Domb A, Elmalak O, Langer R, Swartz HM (1997) Noninvasive in vivo monitoring of drug release and polymer erosion form biodegradable polymers by EPR spectroscopy and NMR imaging. J Pharm Sci 86:126-133.
34. Martin A, Bustamante P, Chun AHC (1993) Physical pharmacy, Fourth Edition. Ed., GH Mundorff. Malvern, PA: Lea & Febiger Press, pp. 534-536.
35. Morris L, Bajpai PK (1989) Development of a resorbable trcalcium posphate (TCP) amine antibiotic composite. In Biomedical Materials and Devices. Eds., JS Hanker and BL Giammara. Pittsburgh, PA: Materials Research Society, pp. 293-300.
36. Munro CJ, Laughlin LS, VonSchalscha T, Baldwin DM, Lasley BL (1996) An enzyme immunoassay for serum and urinary levonorgestrel in human and non-human primates. Contraception 54:43-53.
37. Muse (1996) Package insert information. Vivus Inc. Menlo Park, CA 94025.
38. Otsuka M, Matsuda Y, Yu D, Wong J, Fox JL, Higuchi WL (1990) A novel skeletal drug delivery system for anti-bacterial drugs using self setting hydroxyapatite cement. Chem Pharm Bull 38:3500-3503.
39. Park H, Park K (1996) Biocompatibility issues of implantable drug delivery systems. Pharm Res 13:1770-1776.
40. Parker DR, Bajpai PK (1993) Effect of locally delivered testosterone on bone healing. 19th Annual Meeting of the Society for Biomaterials April 28-May 2: p. 276.
41. Pratesi G, Savi G, Pezzoni G, Bellini O, Penco S, Tinelli S, Zunino F (1985) Poly-L-aspartic acid as a carrier for doxorubicin: a comparative in vivo study of free and polymer-bound drug. The Macmillan Press Ltd 52:841-848.
42. Ranade V (1990) Drug delivery systems 4. Implants in drug delivery. J Clin Pharm 30:871-889.
43. Rhine W, Hsieh DS, Langer R (1980) Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics. J Pharm Sci 69:265-270.
44. Robinson DH, Sampath S (1989) Release kinetics of tobramycin sulfate from polymethylmethacrylate implants. Drug Dev Ind Pharm 15:2339-2357.
45. Sable BA, Dominiak P, Hauser W, During MJ, Freese A (1990) Extended levodopa release form a subcutaneously implanted polymer matrix in rats. Ann Neur 28:714-717.
46. Schade DS, Eaton P, Edwards S, Doberneek RC, Spencer WJ, Cawlson G, Bair RE, Loue JT, Vrenda RS, Gaona JI (1982) A remotely programmable insulin delivery system successful short term implantation in man. JAMA 247:1848-1853.
47. Seligson D, Klemm, K (1989) Antibiotic bone cement combinations. In Orthopaedic Infections. Eds., RD D'Ambrosia and RL Marier, Thorofare, NJ: Slack, pp. 385-417.
48. Smith GS, Galanis JC (1995) One year results of the intraseleral glaucoma implant. J Cat Refr Surg 21:453-456.
49. Thecuwes F, Yum SI (1976) Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulations. Ann Biomed Eng 4:343-353.
50. Uhlig ELP, Graydon WF, Zingg W (1983) The electro osmotic actuation of implantable insulin micropumps. J Biom Res 17:931-943.
51. Wahlig H, Dingeldein E (1980) Antibiotics and bone cements. Experimental and clinical long-term observations. Act Ortho Scand 51:49-56.
52. Whalig H (1981) Gentamicin PMMA beads, a drug delivery system, basic results. In Local Antibiotic Treatment in Osteomyelitis and Soft Tissue Infections. Eds., Th JG van Rens and FH Kayser. Amsterdam: Excerpta, pp. 9-17.
53. Weissleder R, Kirtland P, Robert W, Chun Z, Bogdanov A (1995) Quantitation of slow drug release form an implantable and degradable gentamycin conjugate by in vivo magnetic resonance imaging. Am Soc Microbiol 39:839-845.
54. Willoughby M, Morris LM, Bajpai PK (1989) Local delivery of antibiotics by ceramic composites. 15th Annual Meeting of the Society for Biomaterials April 28-May 2: 179.
55. Wood DA (1980) Biodegradable drug delivery systems. Int J Pharm 7:1-18.
56. Yu D, Wong J, Matsuda Y, Fox J, Higuchi WI, Otsuka M (1992) Self setting hydroxyapatite cement: a novel skeletal drug delivery system for antibiotics. J Pharm Sci 1:529-531.
57. Zaheer S, Lehman J, Stevenson G (1982) Capsular contracture around silicone implants: the role of intraluminal antibiotics. Plast Recon Surg 69:809-812.